{"cik":2130606,"taxonomy":"us-gaap","tag":"ShareBasedCompensation","label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","entityName":"OBSIDIAN THERAPEUTICS, INC.","units":{"USD":[{"start":"2024-01-01","end":"2024-12-31","val":7060000,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28","frame":"CY2024"},{"start":"2025-01-01","end":"2025-06-30","val":4871000,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28"},{"start":"2025-04-01","end":"2025-06-30","val":2762000,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28","frame":"CY2025Q2"},{"start":"2025-01-01","end":"2025-12-31","val":8931000,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28","frame":"CY2025"},{"start":"2026-01-01","end":"2026-06-30","val":3006000,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28"},{"start":"2026-04-01","end":"2026-06-30","val":1552000,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28","frame":"CY2026Q2"}]}}